Featured Image


Allows Medical marijuana?: Yes

Allows Adult-Use marijuana?: No

2018 Medical Sales : $39,000,000

2022 Projected Medical Sales : $101,000,000

2018 Adult Use Sales : N/A

2022 Projected Adult Use Sales : N/A

Noteworthy Information: 
{{COVID-19 Update: The two medical cannabis companies operating in the state have been allowed to remain open. }}

Minnesota has over 1,400 registered and certified health care practitioners and over 14,000 enrolled patients in their medical cannabis program. The Office of Medical Cannabis accepts petitions annually, June 1 – July 31, to add a new qualifying condition and/or delivery method to the MN Medical Cannabis program. Alzheimer’s disease will be a new qualifying condition, taking effect in August 2019.

Is there a Regulatory Structure? (State Agency): Yes (Minnesota Department of Health–Division of Health Policy–Office of Medical Cannabis)

# of Dispensaries Allowed (# issued): 2 “Medical Cannabis Manufacturers” allowed. (2 have been selected.) Both must have four distribution locations, resulting in a total of 8 locations across the state. [Minnesota Medical Solutions operates in Minneapolis, Rochester, Moorhead, and Bloomington. LeafLine Labs operates in Eagan, St. Cloud, Hibbing, and St. Paul.]

# of Cultivations Allowed (# issued): Encompassed by “Medical Cannabis Manufacturers”

# of Manufacturers Allowed (# issued): Encompassed by “Medical Cannabis Manufacturers”

# of Testing labs Allowed (# issued): At least 2 allowed. Each Medical Cannabis Manufacturer contracts with at least 1 lab for testing. 

Geographic Distribution of Licenses: “The distribution facilities shall be located based on geographical need throughout the state to improve patient access.”

Application Fee: 
$6,000.00 non-refundable (for all license types)
Regulatory Assessment – The annual regulatory assessment is a nonrefundable, state-level fee which offsets LARA’s annual
operational costs. The regulatory assessment must be submitted before a license can be issued. The requirements in this subdivision do not apply after June 30, 2018.

Licensing Fees: 
Patient renewal fee: $60
Revised or duplicate copy of the registration identification card fee: $10
[Fees for other licenses have not yet been finalized.]

Residency Requirements: 

Vertical Integration Allowed, Required or Prohibited: 

Medical Marijuana Qualifying Patient Conditions: 
1) Cancer associated with severe/chronic pain, nausea or severe vomiting, or cachexia or severe wasting.
2) Glaucoma.
4) Tourette Syndrome.
5) Amyotrophic Lateral Sclerosis (ALS).
6) Seizures, including those characteristic of Epilepsy.
7) Severe and persistent muscle spasms, including those characteristic of Multiple Sclerosis.
8) Inflammatory bowel disease, including Crohn’s disease.
9) Terminal illness, with a probable life expectancy of less than one year.*
* To qualify for the program, you must suffer from cancer or a terminal illness with a probable life expectancy of under one year, if your illness or its treatment produces one or more of the following: severe or chronic pain; nausea or severe vomiting; or Cachexia or severe wasting.
10) Intractable pain
11) Post-Traumatic Stress Disorder
12) Autism
13) Obstructive Sleep Apnea
14) Alzheimer’s disease (eff. 8/2019)

Testing Required: 
Yes. Random quarterly tests for pesticides.


Please enter your comment!
Please enter your name here